宁德北站小巷子50一次(宁德北站小巷子50一次:为公益而行)

2024-04-20 07:31:50 | 来源:在吗场吗新闻网
小字号

宁德北站小巷子50一次(宁德北站小巷子50一次:为公益而行)

宁德北站小巷子50一次是一家以公益为出发点的组织。我们致力于改善宁德北站附近小巷的环境,并提供基本生活物资给需要帮助的人们。通过一次次的行动,我们希望能为社区带来更多的温暖和希望。

我们的公益组织主要分为两个方面的工作内容。一方面,我们积极组织志愿者进行宁德北站附近小巷的清洁和整治工作。这些小巷通常是交通不方便、环境肮脏、卫生条件差的地方,给附近居民带来很大的不便。我们通过定期组织志愿者进行清理,并且推动当地政府加大对这些小巷的维护力度。通过我们的努力,这些小巷逐渐焕发出了新的面貌。

另一方面,我们也致力于帮助附近居民,特别是那些经济困难的人们。我们会组织募捐活动,筹集到的善款用于购买基本的生活物资,比如食品、衣物、学习用品等。我们会与当地学校、社区合作,确保这些物资真正送到需要帮助的人们手中。我们希望能够减轻他们的负担,给他们带来更多的关爱和希望。

除了直接的行动,我们也通过宣传和教育活动来提高社区居民的环保意识和社会责任感。我们会举办宣讲会、座谈会等活动,向居民介绍环境保护的重要性,鼓励大家从自己做起,共同守护好我们的社区环境。我们也会开展公益义工培训,让更多人参与到公益事业中来,共同传递温暖和希望。

未来,宁德北站小巷子50一次将继续坚守初心,为公益而行。我们将不断拓展我们的宣传和行动范围,努力服务更多的居民,为社区带来更多的改变和发展。我们相信,只要大家心手相连,共同努力,我们一定能够让宁德北站附近的小巷子焕发出勃勃生机,让温暖和希望充满每一个角落。


(责编:admin)

分享让更多人看到

 厚街现在还有巷子吗 (保险行业巷道分析:何以重塑未来?)

厚街现在还有巷子吗 (保险行业巷道分析:何以重塑未来?)

2024-04-20 07:42:51 | 来源:问护题境新闻网
小字号

厚街现在还有巷子吗

保险行业是一个庞大而复杂的行业,其中涉及多种类型的保险。在这个不断变化和发展的行业中,巷子象征着创新和机遇。那么,厚街现在还有巷子吗?下面将通过分析保险业的不同类型,探讨如何重塑未来。

人寿保险

人寿保险是最传统的保险类型之一,它的主要目的是为被保险人提供经济保障,以应对意外事故、疾病或去世等意外情况。然而,在当前的数字化时代,人寿保险业面临着巨大的挑战。保险公司需要通过引入创新的产品和服务,以及通过利用大数据和人工智能等新兴技术,来吸引更多的年轻消费者。此外,保险公司还可以考虑与其他行业合作,提供定制化的保险产品,以满足不同消费者的需求。

财产保险

财产保险是另一种重要的保险类型,它涉及到对个人和企业的财产进行保护。然而,随着自然灾害和人为事故的增加,财产保险面临着越来越大的风险。为了应对这些挑战,保险公司可以通过建立更强大的风险评估和管理体系,提供更全面的保险保障。此外,利用新兴技术如物联网、区块链和云计算等,可以提高保险公司的效率和准确性,从而为客户提供更好的保险服务。

健康保险

健康保险是近年来快速发展的保险类型之一,它涉及到对个人和家庭的健康进行保护。随着医疗费用的不断上涨和人们健康意识的提高,健康保险成为越来越多人的关注焦点。保险公司可以通过引入创新的健康保险产品,以及与医疗机构和健康科技公司等合作,提供更加全面和个性化的健康保险服务。此外,利用大数据分析和人工智能等技术,可以提高保险公司对健康风险的评估能力,从而为客户提供更有效的保险保障。

车辆保险

车辆保险是保险业中的另一个重要领域,它涉及到对汽车及其所有者进行保护。随着智能技术和自动驾驶车辆的快速发展,车辆保险行业面临着巨大的变革。保险公司可以通过引入智能车辆保险产品,以及与汽车制造商和技术公司等合作,提供更加全面和个性化的保险服务。此外,利用车辆数据和人工智能等技术,可以提高保险公司对车辆风险的评估能力,从而为客户提供更准确的保险报价和理赔服务。

总结

保险行业是一个充满机遇和挑战的行业,巷子始终存在。在数字化时代,保险公司需要不断创新和变革,以适应快速变化的市场需求。引入新兴技术和与其他行业的合作,可以帮助保险公司提供更好的保险产品和服务。同时,加强风险管理和提高服务效率,也是保险公司重塑未来的关键。无论是人寿保险、财产保险、健康保险还是车辆保险,都需要保险公司不断创新和改进,以满足不断变化的客户需求。


(责编:admin)

分享让更多人看到

Asia Cell & Gene Therapy Innovation Summit 2024
  • Apr. 2nd - 3rd 2024
  • Shanghai, China

CGT Asia 2024 - The 5th Asia Cell & Gene Therapy Innovation Summit 2024
3DCC 2024 - The 2nd 3D Cell Culture and Organoid R&D Summit
CGT Awards - 2024 Asia Pacific Cell and Gene Therapy Innovation Star of the Year Award

0 +

Keynote
Speeches

0 +

Professional
Attendees

0 +

Featured
Booths

0 +

Global Cell&Gene
Therapy Enterprises

0 +

Media
Reports

Key words of the conference

Commercialization and Innovative Drug Access to Hospitals, Clinically Oriented and Innovative Therapies, Stem Cell Therapy, Extracellular Vesicles Therapy, MSC EV, Cell Therapy, Gene Therapy, RNA Therapy, Oncolytic Virus, Rare Disease, Tumor Microenvironment, Non-coding RNAs, Epigenetic, Single-Cell Sequencing, Biomarkers, Universal Cancer only Maker (UCOM), Immune Cell, TCR-T, CAR-NK, 3D Cell Culture, Organoid Model, CRISPR/CAS9 Gene Editing, iPSC, PCR, High-Throughput Screening, Application Plans,Continuous Production Process, GMP, AAV, (Non-) Viral Vectors, LNP etc.

Chips-on-Organoid, Microfluidic Technology, 3D Bio-Printing,Organoid vascularization, Advances in Cutting-Edge Technologies, Standardization and Application Scenarios, Clinical Research Applications, Drug Sensitivity Screening, R&D Applications, Efficacy Study, Cross-Cutting Technologies, Regenerative Medicine, Discussions on Laws and Regulations, etc.

Topics Highlights
The 5th Asia Cell and Gene Therapy Innovation Summit 2024
  • Case Study of Marketed Targeting CD19 CAR-T Cell Therapy Clinical Trials

  • Progress of Clinical Research on Mesenchymal Stem Cell Therapy for End-Stage Liver Disease

  • Highlights of Before and After Marketing Changes for Cell Therapy Drugs

  • Top CDMO Takes Your Cell Culture from Customization to Global Standardization

  • Role and Mechanisms of Cardiac-Derived Exosomes in Oncological Cardio Therapy

  • Bring In or Going Overseas--How to Accelerate the Commercialization of Cell Therapy?

  • Recent Clinical Advances in Gene Therapy for Hereditary Deafness

  • Novel Malignant Tumor Therapeutic Strategy - Lysovirus Enhances The Anti-Tumor

    Effect of DC Vaccines

  • Efficient Dual AAV Carrier Development Optimization and Design

  • Application and Progress of Small Nucleic Acid Drugs in The Field of Chronic Diseases

    such as Cardiovascular Diseases

  • ......

2024 3D Cell Culture Organoid R&D Summit

  • Regenerative Medicine Through The Eyes of An Investor

  • Microfluidic Chip-Assisted Vascularisation of Human Brain Organoids

  • Construction of Novel Human Endometrial Organoids

  • Research on Human Bionic Organoid and Organ-on-a-Chip Based on Neural Innervation

  • Clinical Case Sharing of Heart Transplantation for Heart Failure

  • Quality Control of Organoid Drug Sensitivity Testing Throughout the Entire Process

  • ......


At a Glance

3-2312121626223a.png


3-231120145302209.png

Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show


Part of Speakers

Prof. Xinhua LIN
Prof. Xinhua LIN

President

School of Life Sciences Fudan University /  Greater Bay Area Institute of Precision Medicine

Prof. Zibing JIN
Prof. Zibing JIN

Deputy President of Beijing Tongren Hospital

Beijing Tongren Hospital Capital Medical University, Beijing Institute of Ophthalmology

Prof. Cheng QIAN
Prof. Cheng QIAN

CSO

Precision Biotech

Prof. Wei ZUO
Prof. Wei ZUO

Chairman

Regend Therapeutics

Prof. Hao SHEN
Prof. Hao SHEN

CSO

FOSUNKite

Dr. Maryland Franklin
Dr. Maryland Franklin

VP

Labcorp

Dr. Aron  JAFFE
Dr. Aron JAFFE

SVP

Chroma Medicine

Prof. Jonathan  Yuin-Han LOH
Prof. Jonathan Yuin-Han LOH

Director

A*STAR IMCB

Dr. Noriyasu ISHIKAWA
Dr. Noriyasu ISHIKAWA

CEO

Solallis Bio Inc.

Dr. David DU
Dr. David DU

Co-founder, CEO

Evergreen Therapeutics

Prof. Hongming HU
Prof. Hongming HU

CSO

ImmuXell

Prof. Guoying ZHOU
Prof. Guoying ZHOU

Chairman & CEO

ImmVira

Dr. Joan SHEN
Dr. Joan SHEN

Founder & CEO

NeuShen Tx

prof. Wenbin Qian
prof. Wenbin Qian

Founder

Rongu bio

Dr. Cecilia ZHANG
Dr. Cecilia ZHANG

CSO

Biosyngen

Mrs. Lanlin WU
Mrs. Lanlin WU

CEO

Carcell Biopharma Ltd.

Dr. Baohong ZHANG
Dr. Baohong ZHANG

CEO

Epigenic Therapeutics, Inc.

Dr. Minmin SUN
Dr. Minmin SUN

Chairman & CEO

Immunofoco

Prof. Alex H. Chang
Prof. Alex H. Chang

CEO

YaKe Biotech

Dr. Huashun LI
Dr. Huashun LI

Chairman

Ascle Therapeutics

Mr. Zhenhua Luo
Mr. Zhenhua Luo

PI

The First Affiliated Hospital of Sun Yat-sen University

Prof. Peng LIU
Prof. Peng LIU

Prof

Tsinghua university

Dr. Adam ZHAO
Dr. Adam ZHAO

Founder

Anlongbio

Dr. Binghe TAN
Dr. Binghe TAN

Co-Partner, Vice President of Production and CMC

BRL Medicine Inc.

Prof. Guoqiang HUA
Prof. Guoqiang HUA

Founder of D1 Medical

D1 MEDICAL TECHNOLOGY

Dr. Jun Li
Dr. Jun Li

CEO

Fundamentatx

Prof.  Bing Zhao
Prof. Bing Zhao

Prof

fudan university

Dr. Yuan CAI
Dr. Yuan CAI

CEO/Co-Founder

Starrygene Therapeutics

PI. Liang Li
PI. Liang Li

PI

southern medical university

Dr. Xiaofang Tang
Dr. Xiaofang Tang

Dr

GBA-IPM

Dr. Yi JIN
Dr. Yi JIN

CEO

GeCell Therapeutics

Mr. Zhihui Weng
Mr. Zhihui Weng

vp

sharecaptal

Dr. Libo ZHAO
Dr. Libo ZHAO

CTO

Echo Biotech

Dr. Andrew LIN
Dr. Andrew LIN

CEO

Lingyi Biotech Co., Ltd.

Dr. Yarong LIU
Dr. Yarong LIU

Founder/CEO

Grit Biotechnology

Dr. Wenmin ZHU
Dr. Wenmin ZHU

Marketing Director

T&L Biotechnology

Prof. Donghui ZHANG
Prof. Donghui ZHANG

Prof

Hubei university

Dr. Lang Zhang
Dr. Lang Zhang

Head of CMC-PD mRNA, in vivo Platform

CorrectSequence Therapeutics

Mr. Yun LIU
Mr. Yun LIU

Chairman/President

Huayi Capital/Huayi Research Institute

Dr. Yu ZHANG
Dr. Yu ZHANG

Founder/CEO

VCANBIO Life Science

Dr. ZhengBo SU
Dr. ZhengBo SU

Chairman

TCRCure Biopharma Ltd.

Dr. Junjie PENG
Dr. Junjie PENG

Chief Physician, Colorectal Surgery

Fudan University Shanghai Cancer Center

Dr. Ming YUAN
Dr. Ming YUAN

Chairman

Huayaokangming

Dr. Ying ZHANG
Dr. Ying ZHANG

Co-founder, CTO

Nuwacell

Dr. Xiang LI
Dr. Xiang LI

Chairman&Founder&CEO

XellSmart

Dr. Qiang CHEN
Dr. Qiang CHEN

CTO

DanausGT

Dr. Xueliang YU
Dr. Xueliang YU

VP

Starna Therapeutics

Mr. Gang LU
Mr. Gang LU

vp

shlifestemcell

Mrs. Zhong ZHAO
Mrs. Zhong ZHAO

BU Head & Chief Product Officer

DXY Insight Database

Dr. Wee Kiat TAN
Dr. Wee Kiat TAN

Co-CEO & COO

CytoMed Therapeutics

Dr. Xuedong DAI
Dr. Xuedong DAI

VP

collectively known as SAFE GLP

Mr. Victor YU
Mr. Victor YU

Country Manager of Greater China

Astrea Bioseparations Ltd

Dr. Lifan WEI
Dr. Lifan WEI

Senior Investigator

INADRD, CSPC

Dr. Zhou LI
Dr. Zhou LI

CSO

Juventas Cell Therapy LLC

Mr. Jack ZHANG
Mr. Jack ZHANG

Strategy and Business Development Lead, CGT APAC

Lonza

Dr. Zhao ZHU
Dr. Zhao ZHU

Co-founder/Chairman/CEO

Neuregen Therapeutics

Dr. Ramin BAGHIRZADE
Dr. Ramin BAGHIRZADE

Global Head Commercial – Gene Therapy CDMO Services

Charles River丨Biologics Solutions

Dr. Wenji DONG
Dr. Wenji DONG

Founder & Chairman

Genmedicn

Dr. Forrest CHEN
Dr. Forrest CHEN

CSO

Zhongying Biomedical

Dr. Gaofeng ZHA
Dr. Gaofeng ZHA

CEO

MagicRNA

Mrs. Wendy LIN
Mrs. Wendy LIN

Key Account Manager

EMBALL'ISO

 Mr.Gary Wang
Mr.Gary Wang

General Manager

kanglitai

Dr. Yang YANG
Dr. Yang YANG

CEO

Genevector Biotech

Dr. Jing FAN
Dr. Jing FAN

Founder & CEO

Hopstem

Mr. Zebin LING
Mr. Zebin LING

CEO

MingCeler

Dr. Ling PENG
Dr. Ling PENG

Medical Director

TCRcure

Prof. Hua LIU
Prof. Hua LIU

Founder, Chief Scientific Officer

Xinghua Bio

Dr. Fan MO
Dr. Fan MO

Co-founder & CEO

Neoantigen

Dr. Xinpo JIANG
Dr. Xinpo JIANG

Associate Vice President of R&D

GenScript

Mrs. Gloria Teng
Mrs. Gloria Teng

Executive Partne

GTJA Investment

Prof. Shuhang WANG
Prof. Shuhang WANG

Attending Doctor

CANCER HOSPITAL CHINESE ACADEMY OF MEDICAL SCIENCE

Mr. Alex CHENG
Mr. Alex CHENG

General Manager

Tofflon

Prof. Zhiyong ZHANG
Prof. Zhiyong ZHANG

Awardee of the First Prize of National Science and Technology Progress Award of China (Top scientific awards in China);Expert of National Talent Program of China;Chief Scientist of REGEN-αGEEK

REGEN-αGEEK

Dr. Luke LI
Dr. Luke LI

BD and Commercial VP

Neurophth Therapeutics

Mrs. Emily TAN
Mrs. Emily TAN

Chief Operating Officer

Unixell Biotechnology

Prof. Mi LIU
Prof. Mi LIU

Founder

Es-Bio

Dr. Hexige Saiyin
Dr. Hexige Saiyin

Assistant professor

Fudan University

Prof. Tianqing LI
Prof. Tianqing LI

Prof

Kunming University of Science and Technology

Dr. Zaozao CHEN
Dr. Zaozao CHEN

CTO

Avatarget

Mr. Chilin WU
Mr. Chilin WU

Partner

DeHeng

Prof. Jie LIU
Prof. Jie LIU

Principal scientist

Eacin Bio

Dr. Lei WANG
Dr. Lei WANG

Department Head of the Cell Resources Center of the National Stem Cell Resource Center

Institute of Zoology, Chinese Academy of Sciences/Beijing Institute of Stem Cell and Regenerative Medicine

Dr. Yi ZHOU
Dr. Yi ZHOU

COO

AimingMed

Prof. Hongju MAO
Prof. Hongju MAO

PI

Shanghai Institute of Microsystems and Information Technology, Chinese Academy of Sciences

Prof. Huaying CHEN
Prof. Huaying CHEN

Prof

Harbin Institute of Technology

Mrs. Katie LI
Mrs. Katie LI

Head of Clinical Operation

CorrectSequence Therapeutics

Dr. Yan XU
Dr. Yan XU

VP

Binhui Biopharm



More guests will continue to update them

Ways to Attend

Increase Your Visibility. Improve Your Reputation

Normal Ticket

  • 1 Pass

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs & Documentation


Exhibition Sponsor

  • 3 Passes

  • 6㎡or 9㎡ Booth for show

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Presentation Sponsor

( Slots Limited)

  • 5 Passes

  • 30 min Speech Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Gold Sponsor

(Exclusive)

  • 5 or More Passes

  • 30 min Speech Opportunity

  • 6or 9 Booth for show

  • Chairman Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Secure your ticket today

Early Bird tickets available now

Secure your spot at CGT Asia our special offer, and don’t go alone, enjoy the best group discount.

Register

Sponsors & Partners

Part of Previous Sponsors

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
26

Part of Media Partners

今日头条
搜狐
药智网
医谷网
CPHI制药在线
会会药咖
镁客网
广动医谷
丁香会议
研发客
肽度
大健康派
生物探索
药源网
基因线上
转化医学网
现代健康网
医药健闻
中国制药设备网
细胞知聊
新康界
医诺医学
美通社
动脉网
医疗器械创新网
新浪医药
中国仪器批发网
细胞世界
戊戌数据
大健康网
嘉裕检测
肽研社
测序宝
基因君
猎药人
化学网
爱爱医
来宝网
生物咖啡茶
生物通
医学信息
中国生物器材网
分析测试百科网
全球医学会议网

Related Meetings

Presentation, Sponsorship and Exhibition

Gina Xu

Tel:86 21 5893 3801 ext.805

Mob:13601679417

Email:gina.xu@taaslabs.com

Media and Marketing Cooperation

Koala Yan

Tel:86 215893 3801 ext. 811

Mob:13341683667

Email:koala.yan@taaslabs.com

Know More Hot and informative Medical News on Biopharma, Cell& Gene etc. Follow Us Now